News
-
-
-
-
PRESS RELEASE
SKAN provides in-depth insight into its growth strategy and pre-approved services on its first Capital Market Day
SKAN Group reveals growth strategy and pre-approved services at first Capital Market Day, confirming mid-term targets and emphasizing competitive advantages through Pre-Approved Services -
PRESS RELEASE
Targeted adjustments to the ‘Rocket & Tigerli’ construction project
Cham Swiss Properties AG plans targeted adjustments to Winterthur's 'Rocket & Tigerli' project following building permit approval, focusing on ground-floor access and top floor usage without anticipating significant delays -
PRESS RELEASE
After Significant Adjustments to the Corporate Structure: Voltabox Achieves Key Milestones in the Turnaround in Q1 2025
Voltabox AG achieves key milestones in the turnaround in Q1 2025 after significant adjustments to corporate structure. Acquisition of EKM Elektronik GmbH impacts financial results positively -
REGULATED PRESS RELEASE
EURAZEO ENREGISTRE UNE FORTE COLLECTE AU PREMIER TRIMESTRE 2025 ET CONFIRME LA BONNE EXECUTION DE SON PLAN DE ROTATION D’ACTIFS
EURAZEO enregistre une forte collecte au premier trimestre 2025 et confirme la bonne exécution de son plan de rotation d'actifs. Bonne croissance des actifs sous gestion et solide performance des sociétés du portefeuille -
REGULATED PRESS RELEASE
EURAZEO REPORTS STRONG FUNDRAISING IN Q1 2025 AND CONFIRMS THE GOOD EXECUTION OF ITS ASSET ROTATION PLAN
Eurazeo reports strong fundraising and successful asset rotation plan execution in Q1 2025, with solid performance in portfolio companies. Shareholder return increased. Focus on sustainability and impact -
REGULATED PRESS RELEASE
Biophytis met en lumière son approche innovante du traitement de l’obésité lors d’une présentation majeure au congrès ECO 2025
Biophytis met en lumière son approche innovante du traitement de l'obésité lors d'une présentation majeure au congrès ECO 2025. Le Dr Serge Camelo présente les dernières données du programme clinique OBA sur BIO101 pour limiter la perte musculaire chez les patients obèses -
REGULATED PRESS RELEASE
Biophytis Highlights Innovative Approach to Obesity Treatment During Key ECO 2025 Presentation
Biophytis highlights innovative approach to obesity treatment at ECO 2025 presentation, showcasing promising results of BIO101 drug candidate targeting muscle loss in obese patients
